- Home
- MARPS vs HOTH Comparison
MARPS vs HOTH Comparison
Compare MARPS & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MARPS
- HOTH
- Stock Information
- Founded
- MARPS 1956
- HOTH 2017
- Country
- MARPS United States
- HOTH United States
- Employees
- MARPS N/A
- HOTH N/A
- Industry
- MARPS Oil & Gas Production
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- MARPS Energy
- HOTH Health Care
- Exchange
- MARPS Nasdaq
- HOTH Nasdaq
- Market Cap
- MARPS 8.7M
- HOTH 8.3M
- IPO Year
- MARPS N/A
- HOTH 2019
- Fundamental
- Price
- MARPS $3.99
- HOTH $1.06
- Analyst Decision
- MARPS
- HOTH Strong Buy
- Analyst Count
- MARPS 0
- HOTH 4
- Target Price
- MARPS N/A
- HOTH $4.75
- AVG Volume (30 Days)
- MARPS 7.7K
- HOTH 673.3K
- Earning Date
- MARPS 01-01-0001
- HOTH 03-27-2025
- Dividend Yield
- MARPS 8.29%
- HOTH N/A
- EPS Growth
- MARPS N/A
- HOTH N/A
- EPS
- MARPS 0.30
- HOTH N/A
- Revenue
- MARPS $945,496.00
- HOTH N/A
- Revenue This Year
- MARPS N/A
- HOTH N/A
- Revenue Next Year
- MARPS N/A
- HOTH N/A
- P/E Ratio
- MARPS $13.30
- HOTH N/A
- Revenue Growth
- MARPS N/A
- HOTH N/A
- 52 Week Low
- MARPS $3.76
- HOTH $0.58
- 52 Week High
- MARPS $6.50
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- MARPS 45.96
- HOTH 42.86
- Support Level
- MARPS $3.90
- HOTH $1.01
- Resistance Level
- MARPS $4.15
- HOTH $1.09
- Average True Range (ATR)
- MARPS 0.14
- HOTH 0.08
- MACD
- MARPS 0.00
- HOTH -0.02
- Stochastic Oscillator
- MARPS 41.51
- HOTH 25.93
About MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.